Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
Clinical Pharmacology and Therapeutics|November 1, 1990
Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patientsJ L Holtzman, A Abrams, R Cutler, et al.Journal of Neurological Surgery. Part B, Skull Base|June 30, 2022
Impact of Type of Treatment Center and Access to Care on Mortality and Survival for Skull Base Chordoma and ChondrosarcomaAdam L Holtzman, James E Bates, Christopher G Morris, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 17, 2001
Epidemiological study of urinary 6beta-hydroxycortisol to cortisol ratios and breast cancer riskW Zheng, F Jin, L A Dunning, et al.Journal of Neuro-Oncology|February 23, 2020
Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort studyMichael S Rutenberg, Ronny L Rotondo, Dinesh Rao, et al.Clinical Pharmacology and Therapeutics|July 1, 1989
The pharmacodynamic and pharmacokinetic interaction between single doses of flecainide acetate and verapamil: effects on cardiac function and drug clearanceJ L Holtzman, D Finley, L Mottonen, et al.Journal of Human Hypertension|December 1, 1994
One year experience of elderly hypertensive patients with isradipine therapyG H Stein, B P Hamilton, J H Hamilton, et al.Acta Oncologica (Stockholm, Sweden)|July 28, 2022
The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignanciesAdam L Holtzman, Michael S Rutenberg, Alexandra N De Leo, et al.Head & Neck|January 24, 2025
Survival, Tumor Control, and Safety Outcomes of Proton Therapy in Sinonasal Cancer Population: A Systematic Review and Meta-AnalysisSrivatsa Surya Vasudevan, Estephania Candelo, Alireza Sharifi, et al.Journal of Neuro-Oncology|January 24, 2023
Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningiomaAdam L Holtzman, Gabriella E Glassman, Roi Dagan, et al.Journal of Neuro-Oncology|March 12, 2022
Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution SeriesMichael S Rutenberg, Adam L Holtzman, Daniel J Indelicato, et al.Pageof 12